AEGON N.V.: Company Profile and SWOT Analysis

World Market Intelligence
February 11, 2012
35 Pages - SKU: WLMI6805878
Apple Inc (AAPL: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/12/2014 | published by: Plunkett Research, Ltd.
Apple Inc (AAPL: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Apple Inc, AAPL: NAS) compared to its top competitors  |  read more...
USD 1,795
ARRIS Group Inc (ARRS: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/12/2014 | published by: Plunkett Research, Ltd.
ARRIS Group Inc (ARRS: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (ARRIS Group Inc, ARRS: NAS) compared to its  |  read more...
USD 1,795
AOL Inc (AOL: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/17/2014 | published by: Plunkett Research, Ltd.
AOL Inc (AOL: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (AOL Inc, AOL: NYS) compared to its top competitors  |  read more...
USD 1,795
Anchor Therapeutics, Inc. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
Anchor Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Anchor Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the Anchor Therapeutics, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Angion Biomedica Corp. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
Angion Biomedica Corp. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Angion Biomedica Corp. - Product Pipeline Review - 2014’, provides an overview of the Angion Biomedica Corp.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
AnGes MG, Inc. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
AnGes MG, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘AnGes MG, Inc. - Product Pipeline Review - 2014’, provides an overview of the AnGes MG, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014’, provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer)’s therapeutic pipeline. This report  |  read more...
USD 2,000
Ascepion Pharmaceuticals, Inc. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
Ascepion Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Ascepion Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Ascepion Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Angie's List Inc (ANGI: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/18/2014 | published by: Plunkett Research, Ltd.
Angie's List Inc (ANGI: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Angie's List Inc, ANGI: NAS) compared to its  |  read more...
USD 1,795
Altria
11/7/2014 | published by: ERC Group
Global, Regional & National Tobacco Players, 2014: Altria Summary “Company Insight: Altria” is a new report by ERC that is the result of ERC's extensive market research covering Altria's profile in the tobacco products market. It provides  |  read more...
USD 975
 

SELECT A LICENSE

    Online Download  USD 120  
    Global Site License  USD 360  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!